# Specification Quality Checklist: Mushroom-Body Valence Learning

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-10-19
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- The stakeholders here are the project's researchers, so neuroscience terms (KC, MBON, PAM, PPL1, glomerulus) and
  the project's own names (decoder, body layer, arms, calibration/held-out seeds) are domain language, as in specs
  017 and 018. No language, file layout or code structure is prescribed.
- Resolved: FR-019 uses the network path first, with a declared decoder rule as fallback if the probe shows the
  network shift is too weak (user choice, 2026-10-19).
- Items marked incomplete require spec updates before `/speckit-clarify` or `/speckit-plan`
